Fresenius Medical Care AG

FME: XETR (DEU)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
h^LOCK|#$!$dLOCK|j<#@D#

Fresenius Medical Care Earnings: Ongoing Margin Expansion Keeps Long-Term Outlook Intact

In the third quarter, Fresenius Medical Care generated 10% organic revenue growth and adjusted earnings per share growth of 37%. Management confirmed its guidance for 2025.

Sponsor Center